Investing.com -- The recently announced U.S.-Ukraine minerals agreement, branded by U.S. President Donald Trump as the ...

INGREZZA, used to treat tardive dyskinesia and Huntington’s disease, saw first quarter net product sales of $545.2 million, up 8% YoY. The company cited record new patient starts and improved gross-to ...

Ameresco, Inc. (NYSE: AMRC) saw its shares soar 12.7% after the energy solutions provider reported better-than-expected first quarter results and reaffirmed its f ...

Investing.com -- Lattice (OTC: LTTC) Semiconductor Corporation (NASDAQ: LSCC) reported first-quarter earnings that met analyst expectations, but its stock fell 2.6% in after-hours trading as the ...

Corcept Therapeutics (NASDAQ: CORT) reported first quarter earnings that beat analyst expectations, but revenue fell short of estimates, sending shares down 8.7% ...